Therapeutic strategies to overcome ALK resistance in cancer /

"Therapeutic Strategies to Overcome ALK Resistance in Cancer, Volume 13, presents current strategies to improve and prolong clinical benefit in ALK driven cancers. Most patients with ALK-driven cancer are sensitive to tyrosine kinase inhibitor (TKI) therapy, but resistance invariably develops....

Full description

Bibliographic Details
Call Number:Libro Electrónico
Other Authors: Friboulet, Luc (Editor)
Format: Electronic eBook
Language:Inglés
Published: London, United Kingdom : Academic Press, an imprint of Elsevier, [2021]
Series:Cancer sensitizing agents for chemotherapy ; v. 13.
Subjects:
Lungs > Cancer > Treatment.
Anaplastic Lymphoma Kinase > antagonists & inhibitors
Lung Neoplasms > drug therapy
Antineoplastic Agents > pharmacology
Protein Kinase Inhibitors > therapeutic use
Poumons > Cancer > Traitement.
Lungs > Cancer > Treatment
Internet Resources.
Index not Present.
Online Access:Texto completo

Internet

Texto completo

Error inesperado del formato de respuesta.
Holdings details from

Similar Items